FGL2 and gastrointestinal stromal tumor: Silencing of FGL2 with siRNA had relatively little effect on cell viability in the GIST48, GIST882, GIST‐T1 and GIST‐T1‐IRO cell lines, whereas silencing of KIT with siRNA decreased cell viability substantially (Figure 4A).